Should We Use Dialyzable β-Blockers in Hemodialysis?

Author

Georgianos P.I., Eleftheriadis T., Liakopoulos V.

Date

2022

Language

en

DOI

10.1016/j.xkme.2022.100468

Keyword

antihypertensive agent

beta adrenergic receptor blocking agent

echocardiography

proportional hazards model

retrospective study

Metadata display

Abstract

[No abstract available]

URI

http://hdl.handle.net/11615/72144

Collections

Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]